Module 1: IMPACT Tobacco Smoking Cessation Training for Community Mental Health Clinics: Why IMPACT?

This activity is supported by a grant funded through the National Institute of Mental Health Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50).

This pilot study is part of the NIMH-funded P50 Johns Hopkins ALACRITY Center.

The focus of the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness is to promote the implementation of evidence-based interventions to reduce premature mortality among consumers with serious mental illness (SMI). In the IMPACT project we are testing an implementation intervention designed to increase provider knowledge, self-efficacy, and the delivery of evidence-based smoking cessation treatment for SMI in community mental health settings.

This is the first of four online learning activities. This module is a brief 15 minute introduction to the IMPACT Project.

Target Audience

This activity is intended for physicians, nurses, psychologists, social workers, and other mental health and medical professionals.

Learning Objectives

At the end of this session, you will be able to:
• Describe the prevalence of smoking in persons with serious mental illness.
• Identify myths and facts about smoking and serious mental illness.
 

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC Contact hours for Nurses
  • 0.25 Category I credits for Social Workers
  • 0.25 CEU Hours for Psychologists
  • 0.25 Participation
Course opens: 
09/08/2020
Course expires: 
09/07/2021
Fee:
$0.00

What is IMPACT?

IMPACT stands for Implementing Action for Smoking Cessation Treatment

This pilot study is part of the NIMH-funded P50 Johns Hopkins ALACRITY Center. The focus of the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness is to translate evidence-based interventions to reduce premature mortality among consumers with serious mental illness (SMI) into community mental health settings in Maryland and nationwide.

We are testing an implementation intervention designed to improve provider knowledge, self-efficacy, and delivery of evidence-based smoking cessation treatment for SMI in community mental health settings. We hope to increase delivery of evidence-based treatment to consumers.

This implementation intervention includes asynchronous online and remotely delivered synchronous trainings, including using an avatar practice module for motivational interviewing skills, treatment protocol, expert consultation and coaching/practice facilitation. Manuals and resources guides are available to support delivery of smoking cessation treatment.

Mental health providers’ extensive experience working with consumers with SMI makes them optimally positioned to deliver effective cessation treatment for tobacco smoking, the leading cause of premature mortality among people with SMI.

Contact us:
Email: impact1@jhmi.edu
 

 

This activity is supported by an educational grant from the National Institute of Mental Health Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50).

About the faculty:

Arlene Dalcin, MS, RD
Study Team Investigator
Johns Hopkins School of Medicine

Ms. Dalcin is a Registered Dietician, health educator, and master Motivational Interviewing trainer with over 25 years of experience in clinical research. As a faculty member at Johns Hopkins School of Medicine her focus is on designing interventions and developing trainings for the prevention and treatment of obesity, hypertension and other chronic health conditions. Ms. Dalcin has developed the educational, avatar, and training materials and is the voice behind some of the online training modules featured in this program.

Gail Daumit, MD, MHS
Center Director, Principal Investigator
Johns Hopkins School of Medicine

Dr. Daumit is a practicing general internist whose research is dedicated to improving the physical health of individuals with serious mental illness and decreasing health disparities in this population. Dr. Daumit is a Samsung Professor of Medicine with joint appointments in the Johns Hopkins Bloomberg School of Public Health and the School of Medicine. She is the ALACRITY Center Director and has been the principal investigator on many randomized trials implementing programs to improve physical health of individuals with serious mental illness.

Faith Dickerson, PhD, MPH
Co-Principal Investigator
Sheppard Pratt Health System

Dr. Dickerson is a clinical psychologist with public health research training. She has been involved in many studies that address interventions to reduce cardiovascular risk and improve the somatic health of persons with mental illness. She has co-directed trials of psychosocial interventions to promote smoking cessation for persons with serious mental illness. Dr. Dickerson directs the Stanley Research Program at Sheppard Pratt Health System.

Joseph Gennusa, PhD, RD, LDN
Community Engagement Core Co-Director
Johns Hopkins School of Medicine

Dr. Gennusa is a Registered Dietician with a doctorate in Health Administration and has directed community nutrition programs in state government. He has extensive experience in high quality data collection in community health settings in a wide array of measures. As Project Director, Dr. Gennusa will work closely with Drs. Daumit and Dickerson on study operations.

Stacy Goldsholl, MA
Intervention Director
Johns Hopkins School of Medicine

Ms. Goldsholl is a kinesiologist and works closely with Ms. Dalcin. She has experience designing, developing content for, and managing lifestyle interventions for persons with serious mental illness including weight loss and smoking cessation. Ms. Goldsholl is extensively trained in Motivational Interviewing and supports interventionists to use a patient-centered approach.

Eden Evins, MD, MPH
William Cox Family Professor of Psychiatry
Harvard Medical School
Director, Center for Addiction Medicine, Massachusetts General Hospital

 Dr. Evins is a psychiatrist whose research focuses on the efficacy of pharmacotherapeutic cessation aids in smokers with and without serious mental illness. Dr. Evins’ studies have led to changes in clinical practice guidelines for smoking cessation for those with serious mental illness. She has extensive experience in directing studies on smoking cessation conducted in community mental health centers. Dr. Evins is the Director of the Massachusetts General Hospital Center for Addiction Medicine.

Cori Cather, PhD
Associate Professor of Psychology
Harvard Medical School
Director, Center of Excellence for Psychosocial and Systemic Research, Massachusetts General Hospital

Dr. Cather is a clinical psychologist whose research focuses on psychosocial interventions to promote physical health among individuals with early psychosis and also those with persistent mental health challenges. She has also developed evidence-based psychosocial smoking cessation interventions. Dr. Cather is the Director of the Center of Excellence for Psychosocial and Systemic Research at the Massachusetts General Hospital Schizophrenia Program in Boston.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she (or a partner or spouse) has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Faculty and Content Planners Disclosures: The following faculty and content planners are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Arlene Dalcin, MS, RD, Gail Daumit, MD, MHS, Faith Dickerson, PhD, MPH, Joseph Gennusa, PhD, RD, LDN, Stacy Goldsholl, MA, Eden Evins, MD, MPH, Cori Cather, PhD, Liz Mace, MHS, MA  and Jen Schulman, BS.

This activity will discuss commercial products including, the use of varenicline, bupropion, and nicotine replacement therapy.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Briana Riemer, MD, Sunil Khushalani, MD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, BCBA and Jennifer Tornabene.

 

Physician Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Sheppard Pratt and Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness. Sheppard Pratt is accredited by the ACCME to provide continuing medical education for physicians. Sheppard Pratt designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Statement: Sheppard Pratt is an approved provider of continuing nursing education by Maryland Nurses Association. The Maryland Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is approved for 0.25 contact hours for nurses.

Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt designates this educational activity for a maximum of 0.25 contact hours for Psychologists.

Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education learning activities and maintains full responsibility for this program.   This training qualifies for 0.25 Category II continuing education units.

Counselors: Sheppard Pratt and Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness encourage counselors to participate until credit for home study is approved for enduring events.

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC Contact hours for Nurses
  • 0.25 Category I credits for Social Workers
  • 0.25 CEU Hours for Psychologists
  • 0.25 Participation

Price

Fee:
$0.00
Please login or register to take this course.

Please make sure you have completed all baseline data collection before starting these trainings. Once you have completed this online module, please take the quiz that accompanies it. You cannot complete the course if you do not complete each module’s quiz. Upon completion of all the quizzes, the certificate for the course will immediately appear in your account and the event will be listed on your transcript.

Contact us:
Email: impact1@jhmi.edu

 

Required Hardware/software


This site is best viewed on the two most recent stable releases of the following browsers for all public pages:
PCs Running Windows
•    Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
•    Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play.
•    Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.sheppardpratt.org” and “cdn.sheppardpratt.org” under “add exceptions”.
Apple Computers Running OSX
•    Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
•    Safari
•    Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.sheppardpratt.org” and “cdn.sheppardpratt.org” under “add exceptions”.
This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@sheppardpratt.org and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.